View More View Less
  • 1 Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged Dóm tér 10, H-6720 Szeged, Hungary
  • | 2 Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged Dóm tér 10, H-6720 Szeged, Hungary
  • | 3 2nd Department of Medicine and Cardiology Center, Faculty of Medicine, University of Szeged Szeged, Hungary
  • | 4 Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged Dóm tér 10, H-6720 Szeged, Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Myelodysplastic syndrome (MDS) is a family of clonal disorders characterized by dyshematopoiesis and susceptibility to acute myelogenous leukemia. Tumor necrosis factor-a (TNF-a) and transforming growth factor-b (TGF-b) are cytokines that play key roles in the pathogenesis of MDS. There have been several reports on the presence of genetic polymorphisms in the DNA sequence encoding the leader sequence of the TGF-b 1 protein, and in the -308 promoter region of TNF-a. The association between TNF-a and TGF-b 1 gene polymorphism and the susceptibility to MDS and the progression of the disease was investigated. As compared with healthy control subjects (n = 74), patients with MDS (n = 55) showed no significant deviations in genotype or allele frequencies of TNF-a. Similarly, there were no differences in the distribution of TNF-a genotypes between the MDS patients with only anemia (mild group) and those with bi- or pancytopenia (severe group). On the other hand the TT homozygosity at codon 10 in exon 1 of TGF-b 1 gene was associated with a severe degree of cytopenia [95% CI OR = 4.889, p = 0.0071]. These findings suggest that the investigated genetic polymorphisms do not predispose to the development of MDS, but that TGF-b 1 gene polymorphism may affect the disease progression.

  • Awad, M. R., El-Gamel, A., Hasleton, P., Turner, D. M., Sinnott, P. J., Hutchinson, I. V.: Genotypic variation in the transforming growth factor-betal gene: association with transforming growth factor-betal production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66, 1014-1020 (1998).

    'Genotypic variation in the transforming growth factor-betal gene: association with transforming growth factor-betal production, fibrotic lung disease, and graft fibrosis after lung transplantation. ' () 66 Transplantation : 1014 -1020.

    • Search Google Scholar
  • Arkwright, P. D., Laurie, S., Super, M., Pravica, V., Schwarz, M. J., Webb, A. K., Hutchinson, I. V.: TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 55, 459-462 (2000).

    'TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. ' () 55 Thorax : 459 -462.

    • Search Google Scholar
  • Hinke, V., Seck, T., Clanget, C., Scheidt-Nave, C., Ziegler, R., Pfeilschifter, J.: Association of transforming growth factor-beta 1 (TGF-betal) T29 → C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta 1 in a population-based sample of postmenopausal German women. Calcified Tissue Intern 69, 315-320 (2001).

    'Association of transforming growth factor-beta 1 (TGF-betal) T29 → C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta 1 in a population-based sample of postmenopausal German women. ' () 69 Calcified Tissue Intern : 315 -320.

    • Search Google Scholar
  • Tang, G. J., Huang, S. L., Yien, H. W., Chen, W. S., Chi, C. W., Wu, C. W., Lui, W. Y., Chiu, J. H., Lee, T. Y.: Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 28, 2733-2736 (2000).

    'Tumor necrosis factor gene polymorphism and septic shock in surgical infection. ' () 28 Crit Care Med : 2733 -2736.

    • Search Google Scholar
  • Holweg, C. T., Baan, C. C., Niesters, H. G., Vantrimpont, P. J., Mulder, P. G., Maat, A. P., Weimar, W., Balk, A. H.: TGF-beta 1 gene polymorphisms in patients with end-stage heart failure. J Heart Lung Transplant 20, 979-984 (2001).

    'TGF-beta 1 gene polymorphisms in patients with end-stage heart failure. ' () 20 J Heart Lung Transplant : 979 -984.

    • Search Google Scholar
  • Warle, M. C., Farhan, A., Metselaar, H. J., Hop, W. C., Perrey, C., Zondervan, P. E., Kap, M., de Rave, S., Kwekkeboom, J., Ijzermans, J. N., Tilanus, H. W., Pravica, V., Hutchinson, I. V., Bouma, G. J.: Cytokine gene polymorphisms and acute human liver graft rejection. Liver Transpl 8, 603-611 (2002).

    'Cytokine gene polymorphisms and acute human liver graft rejection. ' () 8 Liver Transpl : 603 -611.

    • Search Google Scholar
  • Xaubet, A., Marin-Arguedas, A., Lario, S., Ancochea, J., Morell, F., Ruiz-Manzano, J., Rodriguez-Becerra, E., Rodriguez-Arias, J. M., Inigo, P., Sanz, S., Campistol, J., M., Mullol, J., Picado, C.: Transforming growth factor-beta 1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168, 431-435 (2003).

    'Transforming growth factor-beta 1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. ' () 168 Am J Respir Crit Care Med : 431 -435.

    • Search Google Scholar
  • Clancy, R. M., Backer, C. B., Yin, X., Kapur, R. P., Molad, Y., Buyon, J. P.: Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 171, 3253-3261 (2003).

    'Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. ' () 171 J Immunol : 3253 -3261.

    • Search Google Scholar
  • Rosenfeld, C., List, A.: A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies. Leukemia 14, 2-8 (2000).

    'A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies. ' () 14 Leukemia : 2 -8.

    • Search Google Scholar
  • Perrey, C., Turner, S. J., Pravica, V., Howell, W. M., Hutchinson, I. V.: ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms. Transplant Immunology 7, 127-128 (1999).

    'ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms. ' () 7 Transplant Immunology : 127 -128.

    • Search Google Scholar
  • McGuire, W., Knight, J. C., Hill, A. V., Allsopp, C. E., Greenwood, B. M., Kwiatkowski, D.: Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Inf Dis 179, 287-290 (1999).

    'Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. ' () 179 J Inf Dis : 287 -290.

    • Search Google Scholar
  • Roodman, G. D., Bird, A., Hutzler, D., Montgomery, W.: Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Exp Haematol 15, 928-935 (1987).

    'Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. ' () 15 Exp Haematol : 928 -935.

    • Search Google Scholar
  • Gersuk, G. M., Beckham, C., Loken, M. R., Kiener, P., Anderson, J. E., Farrand, A., Troutt, A. B., Ledbetter, J. A., Deeg, H. J.: A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol 103, 176-188 (1998)).

    'A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. ' () 103 Br J Haematol : 176 -188.

    • Search Google Scholar
  • Bathgate, A. J., Pravica, V., Perrey, C., Therapondos, G., Plevris, J. N., Hayes, P. C., Hutchinson, I. V.: The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta 1 genes in acute hepatic allograft rejection. Transplantation 69, 1514-1517 (2000).

    'The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta 1 genes in acute hepatic allograft rejection. ' () 69 Transplantation : 1514 -1517.

    • Search Google Scholar
  • Nadel, S., Newport, M. J., Booy, R., Levin, M.: Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 174, 878-880 (1996).

    'Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. ' () 174 J Infect Dis : 878 -880.

    • Search Google Scholar
  • Stoll, C., Mengsteab, S., Stoll, D., Riediger, D., Gressner, A. M., Weiskirchen, R.: Analysis of polymorphic TGFBI codons 10, 25, and 263 in a German patient group with non-syndromic cleft lip, alveolus, and palate compared with healthy adults. BMC Medical Genetics 5, 15 (2004)).

    'Analysis of polymorphic TGFBI codons 10, 25, and 263 in a German patient group with non-syndromic cleft lip, alveolus, and palate compared with healthy adults. ' () 5 BMC Medical Genetics : 15.

    • Search Google Scholar
  • Yokota, M., Ichihara, S., Lin, T. L., Nakashima, N., Yamada, Y.: Association of a T29C polymorphism of the transforming growth factor-betal gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101, 2783-2787 (2000).

    'Association of a T29C polymorphism of the transforming growth factor-betal gene with genetic susceptibility to myocardial infarction in Japanese. ' () 101 Circulation : 2783 -2787.

    • Search Google Scholar
  • Turner, D., Grant, S. C., Yonan, N., Sheldon, S., Dyer, P. A., Sinnott, P. J., Hutchinson, I. V.: Cytokine gene polymorphism and heart transplant rejection. Transplantation 64, 776-779 (1997).

    'Cytokine gene polymorphism and heart transplant rejection. ' () 64 Transplantation : 776 -779.

    • Search Google Scholar
  • Azzawi, M., Hasleton, P. S., Turner, D. M., Yonan, N., Deiraniya, A. K., Sinnott, P. J., Hutchinson, I. V.: Tumor necrosis factor-alpha gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipients. Hum Immunol 62, 140-142 (2001).

    'Tumor necrosis factor-alpha gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipients. ' () 62 Hum Immunol : 140 -142.

    • Search Google Scholar
  • Gersuk, G. M., Beckham, C., Loken, M. R., Kiener, P., Anderson, J. E., Farrand, A., Troutt, A. B., Ledbetter, J. A., Deeg, H. J.: A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol 103, 176-188 (1998).

    'A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. ' () 103 Br J Haematol : 176 -188.

    • Search Google Scholar
  • Raza, A., Gezer, S., Mundle, S., Gao, X. Z., Alvi, S., Borok, R., Rifkin, S., Ifikhar, A., Shetty, V., Parcharidou, A.: Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 86, 268-276 (1995).

    'Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. ' () 86 Blood : 268 -276.

    • Search Google Scholar
  • Moldoveanu, E., Moicean, A., Vidulescu, C., Marta, D., Colita, A.: Apoptotic rate in patients with myelodisplastic syndrome treated with modulatory compounds of pro-apoptotic cytokines. J Cell Mol Med 7, 313-321 (2003).

    'Apoptotic rate in patients with myelodisplastic syndrome treated with modulatory compounds of pro-apoptotic cytokines. ' () 7 J Cell Mol Med : 313 -321.

    • Search Google Scholar
  • Kiss, C., Benko, I., Kovacs, P.: Leukemic cells and the cytokine patchwork. Pediatr Blood Cancer 42, 113-121 (2004).

    'Leukemic cells and the cytokine patchwork. ' () 42 Pediatr Blood Cancer : 113 -121.

  • Molnar, L., Berki, T., Hussain, A., Nemeth, P., Losonczy, H.: Detection of TNFα expression in the bone marrow and determination of TNFa production of peripheral blood mononuclear cells in myelodysplastic syndrome. Pathol Oncol Res 6, 18-23 (2000).

    'Detection of TNFα expression in the bone marrow and determination of TNFa production of peripheral blood mononuclear cells in myelodysplastic syndrome. ' () 6 Pathol Oncol Res : 18 -23.

    • Search Google Scholar
  • Blobe, G. C., Schiemann, W. P., Lodish, H. F.: Role of transforming growth factor beta in human disease. N Engl J Med 342, 1350-1358 (2000).

    'Role of transforming growth factor beta in human disease. ' () 342 N Engl J Med : 1350 -1358.

    • Search Google Scholar
  • Bruno, E., Horrigan, S. K., Van Den Berg, D., Rozler, E., Fitting, P. R., Moss, S. T., Westbrook, C., Hoffman, R.: The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis. Blood 91, 1917-1923 (1998).

    'The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis. ' () 91 Blood : 1917 -1923.

    • Search Google Scholar
  • Allampallam, K., Shetty, V., Mundle, S., Dutt, D., Kravitz, H., Reddy, P. L., Alvi, S., Galili, N., Saberwal, G. S., Anthwal, S., Shaikh, M. W., York, A., Raza, A.: Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome. Int J Hematol 75, 289-297 (2002).

    'Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome. ' () 75 Int J Hematol : 289 -297.

    • Search Google Scholar
  • Maciejewski, J. P., Risitano, A. M., Sloand, E. M., Wisch, L., Geller, N., Barrett, J. A., Young, N. S., Ristiano, A. M.: A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome. Br J Haematol 117, 119-126 (2002).

    'A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome. ' () 117 Br J Haematol : 119 -126.

    • Search Google Scholar
  • Greenberg, P.: Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines. Ann Rheum Dis 60 Suppl 3), iii 41-42 (2001).

    'Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines. ' () 60 Ann Rheum Dis : iii -42.

    • Search Google Scholar
  • Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., Duff, G. W.: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94, 3195-3199 (1997).

    'Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. ' () 94 Proc Natl Acad Sci USA : 3195 -3199.

    • Search Google Scholar
  • Wood, N. A., Thomson, S. C., Smith, R. M., Bidwell, J. L.: Identification of human TGF-betal signal (leader) sequence polymorphisms by PCR-RFLP. J Immunol Methods 234, 117-122 (2000).

    'Identification of human TGF-betal signal (leader) sequence polymorphisms by PCR-RFLP. ' () 234 J Immunol Methods : 117 -122.

    • Search Google Scholar
  • Bouma, G., Crusius, J. B., Oudkerk Pool, M., Kolkman, J. J., von Blomberg, B. M., Kostense, P. J., Giphart, M. J., Schreuder, G. M., Meuwissen, S. G., Pena, A. S.: Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 43, 456-463 (1996).

    'Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. ' () 43 Scand J Immunol : 456 -463.

    • Search Google Scholar
  • Hellström-Lindberg, E., Willman, C., Barrett, A. J., Saunthararajah, Y.: Achievements in understanding and treatment of myelodysplastic syndromes. Hematology (Am Soc Hematol Educ Program) 110-132 (2000).

  • Greenberg, P. L., Young, N. S., Gattermann, N.: Myelodysplastic syndromes. Hematology (Am Soc Hematol Educ Program) 136-161 (2002).

  • Hofmann, W. K., Seipelt, G., Ottmann, O. G., Kalina, U., Koschmieder, S., Brucher, J., Frickhofen, N., Klausmann, M., Mitrou, P. S., Hoelzer, D.: Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels. Ann Hematol 79, 255-258 (2000).

    'Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels. ' () 79 Ann Hematol : 255 -258.

    • Search Google Scholar
  • Wilson, A. G., di Giovine, F. S., Blakemore, A. I., Duff, G. W.: Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1, 353 (1992).

    'Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. ' () 1 Hum Mol Genet : 353.

    • Search Google Scholar

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jan 2021 0 0 0
Feb 2021 0 0 0
Mar 2021 4 0 0
Apr 2021 1 0 0
May 2021 0 0 0
Jun 2021 1 0 0
Jul 2021 0 0 0